ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995

NIH Director’s Office Funds $106 Million In Cancer Grants With Stimulus Dollars

September 18, 2009

Group Opposes Bill To Allow Drug Sales After Phase I.

May 26, 2006

NCAB To Consider Fate Of Existing Two Proposed Comp Center At Important Meeting

April 28, 1978

Senior Biomedical Service Proposed To Increase Pay

April 1, 1988

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014